Medical News

RSS

Scientist examines tungsten contamination in drinking water

A Kansas State University scientist is digging deep to solidify information about potential tungsten contamination in the nation's groundwater and aquifers.

28 Jan 2011

New insight on rehabilitating brain function in addicts

People with addictions to stimulants tend to choose instant gratification or a smaller but sooner reward over a future benefit, even if the future reward is greater. Reduced value of a future reward, called "delay discounting" by neuroscientists, is the major challenge for treatment of addiction. A new study in the February 2011 (Vol. 69, Issue 3) Biological Psychiatry appears to present a strategy for increasing the value of future rewards in the minds of addicts.

28 Jan 2011

ACP details challenges facing the U.S. health care system

"The United States is facing an unprecedented crisis in our health care system," reported J. Fred Ralston Jr., president of the American College of Physicians (ACP), at today's annual State of the Nation's Health Care briefing. "We face a crisis in affordable health insurance coverage. We have more uninsured people than ever before. We still are facing a crisis in access to primary care. Health care costs are increasing at rates that the country-and individual families-can't afford."

28 Jan 2011

Maternal deaths related to IVF are a key indicator of risks to older women

Although still rare, maternal deaths related to in vitro fertilisation (IVF) are a key indicator of risks to older women, those with multiple pregnancy and those with underlying disease, warn experts in an editorial published on bmj.com today.

28 Jan 2011

Tarceva Phase III EURTAC study in NSCLC patients with EGFR activating mutations meets primary endpoint

Genentech, a member of the Roche Group and OSI Pharmaceuticals, a wholly owned subsidiary of Astellas U.S. Holding Inc., a holding company owned by Astellas Pharma Inc., today announced that an independent data monitoring committee has recommended that the Phase III EURTAC study be stopped early because the study met its primary endpoint.

28 Jan 2011

Phase II trial finds fostamatinib ineffective in RA patients not responsive to biologic agents

In a previous study, rheumatoid arthritis (RA) patients who failed to respond to methotrexate were shown to experience positive results with fostamatinib disodium (R788), an oral spleen tyrosine kinase (Syk) inhibitor that is thought to block immune cell signaling involved with bone and cartilage destruction. In the current study, RA patients who failed to respond to biologic agents were studied.

28 Jan 2011

Cetero Research completes 20,000th early-phase clinical study

Cetero Research, the leading early-stage contract research organization, today announced that it has reached another industry milestone with the completion of its 20,000th early-phase clinical study.

28 Jan 2011

Effective fusion of consumer technology and front line medicine needed

Government spending cuts and the high cost of distributed healthcare provision could mean a major shift toward home-based patient care. Lack of resource, increased travel time and an aging population is leading some to consider a more viable alternative. However, limited broadband Internet access in remote areas means that joined up policy changes are needed to ensure an effective solution is achieved.

28 Jan 2011

Initiative to protect patients from inadequately trained practitioners performing surgery

Today the Virginia Society of Plastic Surgeons (VASPS) announced its initiative to work with the Virginia Board of Medicine to protect patients in Virginia from inadequately trained practitioners performing surgery in outpatient offices.

28 Jan 2011

Transcranial magnetic stimulation helps rats to learn more quickly

What sounds like science fiction is actually possible: thanks to magnetic stimulation, the activity of certain brain nerve cells can be deliberately influenced. What happens in the brain in this context has been unclear up to now. Medical experts from Bochum under the leadership of Prof. Dr. Klaus Funke (Department of Neurophysiology) have now shown that various stimulus patterns changed the activity of distinct neuronal cell types.

28 Jan 2011

Prototype drug halts GVHD in mouse models of bone marrow transplantation

A prototype drug already shown to hold promise for treating autoimmune disorders like lupus, arthritis and psoriasis halts established graft-versus-host disease (GVHD) in mouse models of bone marrow transplantation, research at the University of Michigan and the University of Florida shows.

28 Jan 2011

Bioniche Life Sciences joins Australian Securities Exchange

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced that it has joined the official list of the Australian Securities Exchange (ASX) and its securities are now trading on that exchange under the code "BNC".

28 Jan 2011

Arena reduces workforce by 25% and provides update on lorcaserin

Arena Pharmaceuticals, Inc. announced today a reduction of its US workforce of approximately 25%, or 66 employees. As a result of the workforce reduction, which Arena plans to complete around March 28, 2011, the company expects to incur restructuring charges, primarily in the first quarter of 2011, of approximately $3.8 million in connection with one-time employee termination costs.

28 Jan 2011

PCMD forms 6M research and analysis network to investigate role of virus infection in type 1 diabetes

The Peninsula College of Medicine and Dentistry (PCMD), University of Exeter, is one of 13 academic institutions and businesses across Europe to form a -6m research and analysis network, funded by the EU for a five-year period, which is designed to investigate the possible role of virus infection in the cause of type 1 diabetes.

28 Jan 2011

Taxol drug promotes regeneration of nerve cells in CNS after spinal cord injury: Study

In a study published today in Science, a global research team reports that the cancer drug Taxol promotes the regeneration of injured nerve cells in the central nervous system after spinal cord injury.

28 Jan 2011

Preclinical data on Inovio’s intradermal electroporation delivery devices presented at Phacilitate Vaccine Forum

Inovio Pharmaceuticals, Inc., a leader in the development of novel therapeutic and preventive vaccines against cancers and infectious diseases, announced today the presentation of recent preclinical data using its next generation of minimally invasive intradermal (skin) electroporation delivery devices at the Phacilitate Vaccine Forum 2011 in Washington, DC.

28 Jan 2011

ALS Biopharma receives ADDF grant to develop therapeutics against Alzheimer's disease

The Alzheimer's Drug Discovery Foundation announced today that it has awarded a grant of $195,000 to ALS Biopharma, LLC to develop therapeutics targeted at clearing toxic proteins implicated in Alzheimer's disease.

28 Jan 2011

Inovio to use proceeds from $24.3M offering for development of DNA vaccine against cervical dysplasias

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the closing of the sale to a single institutional investor of 21,130,400 shares of its common stock and warrants to purchase up to 10,565,200 additional shares of its common stock.

28 Jan 2011

USPTO issues Notice of Allowances to Lakewood's three patent applications for treatment of HUS

Lakewood-Amedex, a leading developer of novel anti-infective pharmaceuticals, announced today that the United States Patent and Trademark Office has issued Notice of Allowances on three patent applications relating to the use of novel monoclonal antibodies for the treatment of hemolytic uremic syndrome caused by shiga toxin II secreting E.coli O157: H7 strain.

28 Jan 2011

World Economic Forum launches risk network to address financial, food security risks

The World Economic Forum launched the Risk Response Network (RRN) at its meeting, which opened Wednesday in Davos, Switzerland, the Economic Times reports.

28 Jan 2011

Medical News

Scientist examines tungsten contamination in drinking water

New insight on rehabilitating brain function in addicts

ACP details challenges facing the U.S. health care system

Maternal deaths related to IVF are a key indicator of risks to older women

Tarceva Phase III EURTAC study in NSCLC patients with EGFR activating mutations meets primary endpoint

Phase II trial finds fostamatinib ineffective in RA patients not responsive to biologic agents

Cetero Research completes 20,000th early-phase clinical study

Effective fusion of consumer technology and front line medicine needed

Initiative to protect patients from inadequately trained practitioners performing surgery

Transcranial magnetic stimulation helps rats to learn more quickly

Prototype drug halts GVHD in mouse models of bone marrow transplantation

Bioniche Life Sciences joins Australian Securities Exchange

Arena reduces workforce by 25% and provides update on lorcaserin

PCMD forms 6M research and analysis network to investigate role of virus infection in type 1 diabetes

Taxol drug promotes regeneration of nerve cells in CNS after spinal cord injury: Study

Preclinical data on Inovio’s intradermal electroporation delivery devices presented at Phacilitate Vaccine Forum

ALS Biopharma receives ADDF grant to develop therapeutics against Alzheimer's disease

Inovio to use proceeds from $24.3M offering for development of DNA vaccine against cervical dysplasias

USPTO issues Notice of Allowances to Lakewood's three patent applications for treatment of HUS

World Economic Forum launches risk network to address financial, food security risks

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News